207 related articles for article (PubMed ID: 14988404)
21. Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury.
Rakhit RD; Kabir AN; Mockridge JW; Saurin A; Marber MS
Biochem Biophys Res Commun; 2001 Sep; 286(5):995-1002. PubMed ID: 11527399
[TBL] [Abstract][Full Text] [Related]
22. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
23. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
24. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
25. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite.
Kim JY; Choi JA; Kim TH; Yoo YD; Kim JI; Lee YJ; Yoo SY; Cho CK; Lee YS; Lee SJ
J Cell Physiol; 2002 Jan; 190(1):29-37. PubMed ID: 11807808
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of S/G2 phase CDK4 reduces mitotic fidelity.
Burgess A; Wigan M; Giles N; Depinto W; Gillespie P; Stevens F; Gabrielli B
J Biol Chem; 2006 Apr; 281(15):9987-95. PubMed ID: 16476733
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
Tsai MS; Weng SH; Chen HJ; Chiu YF; Huang YC; Tseng SC; Kuo YH; Lin YW
Mol Cancer Ther; 2012 Mar; 11(3):561-71. PubMed ID: 22053010
[TBL] [Abstract][Full Text] [Related]
28. Sodium nitroprusside activates p38 mitogen activated protein kinase through a cGMP/PKG independent mechanism.
Rabkin SW; Klassen SS; Tsang MY
Life Sci; 2007 Aug; 81(8):640-6. PubMed ID: 17707440
[TBL] [Abstract][Full Text] [Related]
29. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
[TBL] [Abstract][Full Text] [Related]
30. Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression.
Kan W; Zhao KS; Jiang Y; Yan W; Huang Q; Wang J; Qin Q; Huang X; Wang S
Shock; 2004 Mar; 21(3):281-7. PubMed ID: 14770043
[TBL] [Abstract][Full Text] [Related]
31. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
Ling X; Bernacki RJ; Brattain MG; Li F
J Biol Chem; 2004 Apr; 279(15):15196-203. PubMed ID: 14722122
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
Xu L; Fu Y; Li Y; Han X
Cancer Chemother Pharmacol; 2017 Aug; 80(2):235-242. PubMed ID: 28597042
[TBL] [Abstract][Full Text] [Related]
33. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
34. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
35. Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras.
Sommer KW; Schamberger CJ; Schmidt GE; Sasgary S; Cerni C
Oncogene; 2003 Jul; 22(27):4266-80. PubMed ID: 12833149
[TBL] [Abstract][Full Text] [Related]
36. Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2.
Sarker KP; Biswas KK; Rosales JL; Yamaji K; Hashiguchi T; Lee KY; Maruyama I
J Neurochem; 2003 Dec; 87(6):1345-53. PubMed ID: 14713291
[TBL] [Abstract][Full Text] [Related]
37. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells.
Fukuda S; Foster RG; Porter SB; Pelus LM
Blood; 2002 Oct; 100(7):2463-71. PubMed ID: 12239157
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
Jiao JW; Wen F
Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
[TBL] [Abstract][Full Text] [Related]
40. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
Chuang SM; Liou GY; Yang JL
Carcinogenesis; 2000 Aug; 21(8):1491-500. PubMed ID: 10910949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]